Table 3.
Summary of in vivo studies.
| Phytocompounds | In vivo model | Results | References |
|---|---|---|---|
| Bisphenol A | Different ASD animal models | Modulates the function of the reproductive system, metabolism, and brain functions | [164] |
| Green tea | ASD mice model | Neuroprotective and antioxidant properties, and improvement of behavior | [166] |
| Piperine | ASD murine model | Antioxidant, neuroprotective, anxiolytic, and cognition-enhancing effects | [167–169] |
| Resveratrol | VPA-induced ASD rats | Activates sirtuins and decreases IL-6, TNF-α, NF-κB, and T cells | [80, 173] |
| Resveratrol | Propanoic acid-induced ASD rats | Reduces neuroinflammation, mitochondrial dysfunction, and oxidative/nitrosative stress | [81] |
| Curcumin | ASD rats | Increases GSH levels and reduces inflammation, mitochondrial dysfunction, and oxidative/nitrosative stress | [73, 176] |
| B. monnieri | ASD murine model | Improvement of behavior and antioxidant, anxiolytic, and analgesic properties | [181] |
| Ginsenoside-rich extract | ASD mice model | Improvement of behavior and locomotor activity | [83] |
| Co-ultra-PEA-LUT | ASD murine model | Reduces proimflammatory markers (nitrotyrosine and NF-κB), improves neuroplasticity and neurogenesis, and modulates apoptosis | [186] |
| PEA | BTBR T+tf/J mice | Reduces mitochondrial dysfunction and inflammatory effects Improvement of behavior, PPAR-α activation Microbiota-gut-brain axis regulation |
[187] |